These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 581591)

  • 1. Homologous and heterologous antibody responses to subunit influenza virus vaccine.
    Feery BJ; Evered MG; Hayes K
    J Hyg (Lond); 1978 Dec; 81(3):331-6. PubMed ID: 581591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dose on antibody response to subunit influenza vaccine.
    Feery BJ; Hampson AW; Forsyth JR; Evered MG
    Med J Aust; 1977 Sep; 2(10):324-7. PubMed ID: 927252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Hobson D; Baker FA; Chivers CP; Reed SE; Sharp D
    J Hyg (Lond); 1970 Sep; 68(3):369-78. PubMed ID: 4917915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
    Mancini G; Andreoni M; Arangio-Ruiz G; Sarrecchia C; Donatelli I; Resta S; Rozera C; Sordillo P; Rocchi G
    Boll Ist Sieroter Milan; 1982 May; 61(2):85-91. PubMed ID: 7126342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to one and two doses of influenza virus subunit vaccine.
    Feery BJ; Cheyne IM; Hampson AW; Atkinson MI
    Med J Aust; 1976 Feb; 1(7):186, 188-9. PubMed ID: 1272148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variants of influenza B virus.
    Schild GC; Pereira MS; Chakraverty P; Coleman MT; Dowdle WR; Chang WK
    Br Med J; 1973 Oct; 4(5885):127-31. PubMed ID: 4201694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying homologous and heterologous antibody titre rises after influenza virus infection.
    Freeman G; Perera RA; Ngan E; Fang VJ; Cauchemez S; Ip DK; Peiris JS; Cowling BJ
    Epidemiol Infect; 2016 Aug; 144(11):2306-16. PubMed ID: 27018720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attenuated influenza virus vaccine: protection against homologous and heterologous strains of virus.
    Khakoo R; Ganguly R; Waldman R
    Dev Biol Stand; 1977 Jun 1-3; 39():141-8. PubMed ID: 342305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by a polyvalent influenza vaccine and persistence of homologous and heterologous HI antibodies during a period of two epidemic seasons.
    Pyhälä R
    J Hyg (Lond); 1980 Apr; 84(2):237-45. PubMed ID: 7358963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Capacity of anti-influenza subunit vaccines to elicit the formation of heterologous antibodies].
    Profeta ML; Ferrante P
    Boll Ist Sieroter Milan; 1981; 60(4):268-77. PubMed ID: 6895694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
    Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response.
    Pereira MS; Chakraverty P; Schild GC; Coleman MT; Dowdle WR
    Br Med J; 1972 Dec; 4(5842):701-3. PubMed ID: 4646846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.